Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inovio Pharmaceuticals

2.38
-0.0900-3.64%
Volume:436.39K
Turnover:1.05M
Market Cap:126.48M
PE:-0.92
High:2.49
Open:2.49
Low:2.37
Close:2.47
52wk High:5.83
52wk Low:1.30
Shares:53.14M
Float Shares:33.07M
Volume Ratio:3.71
T/O Rate:1.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5888
EPS(LYR):-3.9488
ROE:-140.12%
ROA:-59.30%
PB:4.43
PE(LYR):-0.60

Loading ...

Inovio Pharmaceuticals Inc. Stock Advances 2.9%, Outperforms Peers

Dow Jones
·
Sep 09

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 04

Inovio Pharmaceuticals Inc. Stock Climbs 8.4%, Outperforms Competitors

Dow Jones
·
Sep 03

Inovio Pharmaceuticals Inc. Stock Sheds 3.7%, Underperforms Competitors

Dow Jones
·
Aug 30

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 28

Inovio Pharmaceuticals Inc. Stock Rallies 4.6%, Outperforms Competitors

Dow Jones
·
Aug 27

Inovio Pharmaceuticals Inc. Begins Rolling Submission of BLA for INO-3107 for RRP Treatment, Aiming for FDA Approval by End of 2025

Reuters
·
Aug 26

Inovio to Begin Rolling Submission of Bla for Ino-3107 for the Treatment of Rrp in Adults

THOMSON REUTERS
·
Aug 26

Inovio Pharmaceuticals Inc - Bla Submission on Track for 2H25, FDA Acceptance by End 2025

THOMSON REUTERS
·
Aug 26

Inovio Pharmaceuticals Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Reuters
·
Aug 25

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 23

Inovio Pharmaceuticals Inc. Stock Advances 3.2%, Outperforms Market

Dow Jones
·
Aug 22

Inovio Pharmaceuticals Inc. Stock Falls 4.6%, Underperforms Competitors

Dow Jones
·
Aug 21

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 19

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 16

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Aug 15

Inovio Pharmaceuticals Reports Q2 2025 Results: Net Loss Decreases to $23.5M, EPS Improves to $0.61 per Share

Reuters
·
Aug 13

Inovio Pharmaceuticals Q2 EPS $(0.61) Beats $(0.62) Estimate

Benzinga
·
Aug 13

BRIEF-Inovio Pharmaceuticals Q2 Operating Expenses USD 23.1 Million

Reuters
·
Aug 13

Inovio Pharmaceuticals Inc - on Track to Submit Bla for Ino-3107 in 2H25

THOMSON REUTERS
·
Aug 13